Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elena Ballini"'
Autor:
Enrico Mossello, Elena Ballini, Anna Maria Mello, Francesca Tarantini, David Simoni, Samuele Baldasseroni, Niccolò Marchionni
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2011 (2011)
Alzheimer's Disease (AD) is the most frequent form of dementia and represents one of the main causes of disability among older subjects. Up to now, the diagnosis of AD has been made according to clinical criteria. However, the use of such criteria do
Externí odkaz:
https://doaj.org/article/1b98f3fd3da248efa74014d2344ad76c
Autor:
Enrico Mossello, Elena Ballini
Publikováno v:
Therapeutic Advances in Chronic Disease. 3:183-193
A methodological approach to quality of life (QoL) assessment in Alzheimer’s disease (AD) is challenging and few clinical trials have included it among outcomes, with conflicting results. In this review an indirect appraisal of evidence has been pe
Autor:
David Simoni, Enrico Mossello, Anna Maria Mello, Samuele Baldasseroni, Elena Ballini, Francesca Tarantini, Niccolò Marchionni
Publikováno v:
International Journal of Alzheimer's Disease
International Journal of Alzheimer's Disease, Vol 2011 (2011)
International Journal of Alzheimer's Disease, Vol 2011 (2011)
Alzheimer's Disease (AD) is the most frequent form of dementia and represents one of the main causes of disability among older subjects. Up to now, the diagnosis of AD has been made according to clinical criteria. However, the use of such criteria do
Autor:
Anna Maria Mello, Matteo Monami, Enrico Mossello, Samuele Baldasseroni, Giuseppe Lonetto, Marta Boncinelli, Francesca Tarantini, Elena Ballini, Edoardo Mannucci, Niccolò Marchionni
Publikováno v:
Experimental Diabetes Research
Experimental Diabetes Research, Vol 2011 (2011)
Experimental Diabetes Research, Vol 2011 (2011)
Metabolic and neurodegenerative disorders have a growing prevalence in Western countries. Available epidemiologic and neurobiological evidences support the existence of a pathophysiological link between these conditions. Glucagon-like peptide 1 (GLP-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ab4cd22c16a31fc4488d7195f70814
http://hdl.handle.net/2158/606314
http://hdl.handle.net/2158/606314